Denali Therapeutics Cash from Discontinued Operations Adjustment (Quarterly) Trends

Denali Therapeutics, Inc. (DNLI)

17.99 -0.79 (-4.21%) USD | NASDAQ | Jan 16, 16:00

18.04 +0.05 (+0.28%) After-Hours: 20:00

View Cash from Discontinued Operations Adjustment (Quarterly) for DNLI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Discontinued Operations Adjustment (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

Start Trial

Enovis Corp.	--
Masimo Corp.	--
Protalix Biotherapeutics, Inc.	--
Twist Bioscience Corp.	--
AIM ImmunoTech, Inc.	--